Search results
Results From The WOW.Com Content Network
August 1, 2024 at 10:36 AM. Teladoc Health (NYSE: TDOC) stock, the telemedicine specialist that made the controversial decision to spend $18.5 billion on diabetes care company Livongo in 2020 ...
Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in the United States. [ 4] Primary services include telehealth, [ 5] medical opinions, [ 6] AI and analytics, telehealth devices and licensable platform services. [ 2] In particular, Teladoc Health uses telephone and videoconferencing software as ...
The telehealth stock's prospects look dim. It seems so long ago that Teladoc Health (NYSE: TDOC) was a bit of a market darling. The telemedicine specialist shot to prominence when its services ...
After Teledoc Health (NYSE:TDOC) merged with Livongo last year, the stock underperformed. And now, after a brief surge in early 2021, TDOC stock is stuck in a narrow trading range at between $120 ...
TDOC stock is like a falling knife now. Trying to catch Teledoc at this point is dangerous, risky and without any logic. Teladoc Health (TDOC) has declined 64% in 2022. It’s a bad idea to buy ...
In the latest trading session, Teladoc (TDOC) closed at $190.84, marking a +1.86% move from the previous day.
Teladoc (TDOC) stock gains from from positive earnings pre-announcement and news to acquire InTouch Health.
CEO of Teladoc Health Inc (30-Year Financial, Insider Trades) Jason N Gorevic (insider trades) sold 30,000 shares of TDOC on 02/02/2021 at an average price of $271.06 a share.